Patents by Inventor Daoguang TIAN

Daoguang TIAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11692178
    Abstract: A genetically engineered bacterium includes a genome of the Eschericia coli and a mutant encoding gene hisG* of a Corynebacterium glutamicum ATP phosphoribosyl transferase HisG on the genome, and the gene hisG* is strongly expressed to enhance activity of a key enzyme HisG for histidine synthesis. The gene hisG* has a nucleotide sequence as shown in SEQ ID NO: 1; a copy number of histidine operon genes hisDBCHAFI of the Eschericia coli is further increased on the genome to enhance a terminal synthetic route of histidine; an encoding gene lysE from an arginine/lysine transportprotein of the Corynebacterium glutamicum is further integrated to the genome and strongly expressed to promote the intracellular histidine secrete to the extracellular space; and an encoding gene rocG of glutamate dehydrogenase of Bacillus subtilis is further integrated to the genome and strongly expressed to promote generation of histidine.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: July 4, 2023
    Assignees: ZHEJIANG ZHENYUAN BIOTECH CO., LTD., Tianjin University of Science and Technology
    Inventors: Xixian Xie, Weiming Fan, Heyun Wu, Wei Jiang, Daoguang Tian, Yanna Chen, Yue Zhang, Jianqing Tu
  • Publication number: 20220411833
    Abstract: Disclosed are gene engineering bacteria for producing L-arginine and a construction method and an application of the gene engineering bacteria. According to the method, genes encoding a carbamoyl phosphate synthetase and a gene encoding an L-arginine biosynthesis pathway enzyme are integrated into Escherichia coli; the present invention has analyzed and reconstructed the arginine synthetic pathway and the metabolic flow related to arginine in the entire amino acid metabolic network in E. coli and finally obtained a genetically engineered bacterial strain which has a clear genetic background, carries no plasmids, undergoes no mutagenesis and is capable of stably and efficiently producing L-arginine.
    Type: Application
    Filed: May 15, 2020
    Publication date: December 29, 2022
    Inventors: Xixian XIE, Shuai JIANG, Chenhui WEN, Heyun WU, Yining LIU, Xuan LI, Daoguang TIAN, Bo XIONG
  • Publication number: 20220403348
    Abstract: A genetically engineered bacterium includes a genome of the Eschericia coli and a mutant encoding gene hisG* of a Corynebacterium glutamicum ATP phosphoribosyl transferase HisG on the genome, and the gene hisG* is strongly expressed to enhance activity of a key enzyme HisG for histidine synthesis. The gene hisG* has a nucleotide sequence as shown in SEQ ID NO: 1; a copy number of histidine operon genes hisDBCHAFI of the Eschericia coli is further increased on the genome to enhance a terminal synthetic route of histidine; an encoding gene lysE from an arginine/lysine transportprotein of the Corynebacterium glutamicum is further integrated to the genome and strongly expressed to promote the intracellular histidine secrete to the extracellular space; and an encoding gene rocG of glutamate dehydrogenase of Bacillus subtilis is further integrated to the genome and strongly expressed to promote generation of histidine.
    Type: Application
    Filed: June 18, 2021
    Publication date: December 22, 2022
    Applicants: ZHEJIANG ZHENYUAN BIOTECH CO., LTD., Tianjin University of Science and Technology
    Inventors: Xixian XIE, Weiming FAN, Heyun WU, Wei JIANG, Daoguang TIAN, Yanna CHEN, Yue ZHANG, Jianqing TU